Home/Celldex Therapeutics/Anthony S. Marucci
AS

Anthony S. Marucci

Founder, President, Chief Executive Officer and Director

Celldex Therapeutics

Celldex Therapeutics Pipeline

DrugIndicationPhase
BarzolvolimabChronic Spontaneous Urticaria (CSU)Phase 3
CDX-0159Prurigo Nodularis (PN)Phase 2
CDX-1140Oncology (Solid Tumors)Phase 1/2
CDX-527Oncology (Solid Tumors)Phase 1
CDX-622Inflammatory DiseasesPhase 1
CDX-585Oncology (Solid Tumors)Preclinical